# Pipeline-2027

**Funder:** KWF
**Budget:** €1M–€5M per proposal (phase-dependent)
**Deadline:** 7 July 2026 (Pre-proposal deadline: 7 July 2026, 12:00 noon. Full-proposal deadline: 8 December 2026, 12:00 noon.)
**Duration:** 4–8 years
**Application:** 2-stage: pre-proposal (closes 7 Jul 2026) → full proposal by invitation only (closes 8 Dec 2026) → interviews Mar 2027 → funding decision Apr 2027
**Frequency:** Annual
**Eligible countries:** NL
**Official call:** https://www.kwf.nl/en/forresearchers/funding/pipeline
**Last verified:** 14 June 2026

## Eligibility & scope

Funds academic-led clinical trials (Phase I–III) for new investigational medicinal products in oncology addressing unmet medical needs. Lead institute must be a medical centre or research institute in the Netherlands; public participating parties must be in Europe. Patient involvement is mandatory. Phase I/I-II budget: €1–2.5M; Phase II/III: €1–5M. Proposals must be in English. Public-private partnerships allowed; repurposing of registered drugs is out of scope.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-pipeline-2027-2026-07) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.